// App-Quantinova.ai

THU0342 : DECLINE IN SUBCLINICAL SYSTEMIC SCLEROSIS PRIMARY HEART INVOLVEMENT ASSOCIATES WITH POOR PROGNOSTIC FACTORS AND ACTIVE INTERSTITIAL LUNG DISEASE

Researchers

Presenter

  • R. B. Dumitru

Principal Investigators

  • L. A. Bissell

  • B. Erhayiem

  • G. Fent

  • A. Kidambi

  • G. Abignano

  • J. Greenwood

  • J. Biglands

  • F. Del Galdo

  • S. Plein

  • M. H. Buch

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Leeds Inst of Cardiovascular and Metabolic Med LICAMM, Leeds, United Kingdom

  • National Institute for Health Research, Leeds Biomedical Research Centre, Leeds, United Kingdom

  • Centre for Musculoskeletal Research, School of Biological Sciences, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

  • Diabetes

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved